The similar dynamics of IRF5 activation and ISG expression in SLE patients prompted us to investigate whether the inhibition of IRF5 exerts only the action that equals the effect of inhibition of type I IFNs. The gene discussed is IRF5; the disease is systemic lupus erythematosus.